DIFFERENTIAL DIAGNOSIS OF HEMORRHAGIC VASCULITIS WITH INFECTIOUS EXANTHEMS IN A CHILD: A CLINICAL CASE
DOI:
https://doi.org/10.32345/USMYJ.3(164).2026.197-203Keywords:
Hemorrhagic Vasculitis, IgA Vasculitis, Henoch-Schönlein Purpura, Immunoglobulin A (IgA), Child, Rash, Case Report, TherapyAbstract
Introduction. Hemorrhagic vasculitis (IgA vasculitis or Henoch–Schönlein purpura) in children remains one of the most pressing issues in modern pediatrics and pediatric infectious diseases. The disease is characterized by systemic involvement of small vessels, an immune complex-mediated pathogenesis, and significant clinical variability, which considerably complicates timely diagnosis. Differential diagnosis between IgA vasculitis and infectious exanthems, which are common in children and may mimic the course of vasculitis, requires special attention.
Aim. To determine the key features of the differential diagnosis of IgA vasculitis and infectious diseases presenting with an exanthem in children, based on the analysis of a clinical case and current literature data.
Materials and methods. This article presents a clinical case of hemorrhagic vasculitis in an adolescent, initially considered an acute infectious disease with an exanthem. The course of the illness and rash characteristics are described in detail, which subsequently allowed for differential diagnosis and confirmation of systemic vasculitis. Special emphasis is placed on the importance of laboratory and instrumental examinations, particularly general indicators of inflammatory activity. The role of immunological factors, including immunoglobulin A, in small vessel involvement is discussed. A review of current literature is provided concerning the incidence of Henoch–Schönlein purpura in childhood, pathogenetic features, and risk factors. The role of immunological mechanisms – particularly the deposition of immunoglobulin A immune complexes in vessel walls, leading to complement activation, endothelial damage, and formation of the characteristic clinical syndrome – is highlighted. Triggering factors are also considered, with infectious agents playing a leading role. The role of basic therapy and the use of glucocorticosteroids is highlighted.
Results. An integrated analysis of the presented clinical case and the available literature data indicates that IgA vasculitis is a multifactorial disease in which infectious agents play a major role and requires careful clinical monitoring and thorough differential diagnosis with infectious exanthems.
Conclusions. Timely establishment of the correct diagnosis and the application of modern therapeutic strategies improve the prognosis and reduce the risk of complications. The analysis of results highlights the importance of interdisciplinary collaboration and a comprehensive approach in managing children with exanthematous diseases to optimize the diagnosis and treatment of IgA vasculitis.
References
1. Sugino H, Sawada Y, Nakamura M. IgA Vasculitis: Etiology, Treatment, Biomarkers and Epigenetic Changes. Int J Mol Sci. 2021 Jul 14;22(14):7538. https://doi.org/10.3390/ijms22147538 . PMID: 34299162; PMCID: PMC8307949.
2. Xu L, Li Y, Wu X. IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers. Front Immunol. 2022 Oct 3;13:921864. https://doi.org/10.3389/fimmu.2022.921864 . PMID: 36263029; PMCID: PMC9574357.
3. Lv Y, Fu R, Peng XJ, Wang Y, Yin TT, Deng YQ. Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children. BMC Pediatr. 2023 Aug 24;23(1):423. https://doi.org/10.1186/s12887-023-04243-3 . PMID: 37620917; PMCID: PMC10464207.
4. Parums DV. A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future. Med Sci Monit. 2024 Jan 28;30:e943912. https://doi.org/10.12659/MSM.943912. PMID: 38281080; PMCID: PMC10832303.
5. Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D, Gibson K, Haas M, Abdel-Hafez MA, Adragna M, Brogan P, Kim S, Liu I, Liu ZH, Mantan M, Shima Y, Shimuzu M, Shen Q, Trimarchi H, Hahn D, Hodson E, Pfister K, Alladin A, Boyer O, Nakanishi K; International Pediatric Nephrology Association. IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol. 2025 Feb;40(2):533-569. https://doi.org/10.1007/s00467-024-06502-6 . Epub 2024 Sep 27. PMID: 39331079; PMCID: PMC11666671.
6. Castañeda S, Quiroga-Colina P, Floranes P, Uriarte-Ecenarro M, Valero-Martínez C, Vicente-Rabaneda EF, González-Gay MA. IgA Vasculitis (Henoch-Schönlein Purpura): An Update on Treatment. J Clin Med. 2024 Nov 4;13(21):6621. https://doi.org/10.3390/jcm13216621 . PMID: 39518760; PMCID: PMC11546386.
7. Wang B, Xiang W, Zhu Z, Shen H. The influence of respiratory infections on Henoch-Schönlein purpura in children. BMC Infect Dis. 2025 Jan 24;25(1):118. https://doi.org/10.1186/s12879-025-10514-4 . PMID: 39856587; PMCID: PMC11763152.
8. Roache-Robinson P, Killeen RB, Hotwagner DT. IgA Vasculitis (Henoch-Schönlein Purpura). 2023 Sep 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30725937.

ISSN
ISSN 












